Climb Bio, Inc. (CLYM) vs YD Bio Limited (YDES)

Climb Bio, Inc. CLYM 10.28 +15.90%
YD Bio Limited YDES 6.01 −16.30%

Climb Bio, Inc. and YD Bio Limited are both Biotechnology companies. Climb Bio, Inc. and YD Bio Limited are of similar size ($509.5M and $508.7M).

Metric	CLYM	YDES	Biotechnology median
P/E	n/m	—	10.60
P/S	n/m	—	9.40
P/B	3.27	—	2.13
Price to free cash flow	n/m	—	25.18
EV/EBITDA	n/m	—	0.66
EV/Sales	n/m	—	9.02
Earnings yield	(8.07%)	—	(32.88%)
Free cash flow yield	(6.79%)	—	(23.13%)

Metric	CLYM	YDES	Biotechnology median
Gross margin	—	—	68.51%
Operating margin	0.00%	—	0.00%
Net margin	0.00%	—	0.00%
Free cash flow margin	0.00%	—	0.00%
Return on equity	(27.10%)	—	(51.96%)
Return on assets	(26.27%)	—	(46.06%)
Return on invested capital	(71.73%)	—	0.00%

Metric	CLYM	YDES	Biotechnology median
Revenue growth (TTM)	—	—	6.76%
EPS growth (last fiscal year)	42.48%	—	29.88%
Revenue growth, 5-year CAGR	—	—	9.75%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	CLYM	YDES	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	31.45	—	4.97
Net debt to EBITDA	1.44	—	1.01

Metric	CLYM	YDES	Biotechnology median
Dividend yield	—	—	0.41%
Payout ratio	—	—	—

Metric	CLYM	YDES	Biotechnology median
Market cap	509.46m	508.65m	161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack